Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis.
Seung Kak ShinHyung Joon YimJeong-Han KimChan Uk LeeJong Eun YeonSang Jun SuhYoung-Kul JungYun Soo KimJu Hyun KimOh Sang KwonPublished in: Gut and liver (2021)
PVR and higher FIB-4 index after 2 years of ETV therapy were independent risk factors for HCC. Therefore, efforts to accomplish a complete virological response and reduce the FIB-4 index should be made.